EW Stock News & Catalysts – Edwards Lifesciences

FEATURED

Raised Outlooks and a Cancer Approval Arrive in the Middle of Medicare Open Enrollment

New

NEW YORK, Nov. 9, 2026 /CNW/ -- Market Updates News Commentary - Health care stocks moved higher with the broader market on Monday morning. As of 9:58 a.m. ET, the State Street Health Care Select Sector SPDR ETF was up

Summary

Nov 9, 2026, 11:36 AM ·PRNewswire

RECENT

Edwards Lifesciences Reports Third Quarter Results

Edwards Lifesciences (NYSE:EW) today reported financial results for the quarter ended September 30, 2026. Q3 Financial Highlights Q3 sales grew 10.5% to $1.72 billion1, constant currency2 sales grew 11.2% Q3

Nov 4, 2026, 4:15 PM ·Business Wire

CLASP II TR Trial Demonstrates Superior Clinical, Quality-of-Life Benefits With Edwards PASCAL System

Edwards Lifesciences Corporation (NYSE:EW) today announced that the PASCAL system for tricuspid repair demonstrated superiority compared to medical therapy alone for the six-month primary endpoint of the CLASP II TR

Nov 2, 2026, 1:25 PM ·Business Wire

Progress Trial Demonstrates Edwards TAVR Is Superior to Clinical Surveillance for Moderate AS Patients With At-Risk Features

TAVR delivered more than 30% reduction in the composite endpoint of death or heart failure event as compared with clinical surveillance; results published in NEJM TAVR demonstrated unparalleled safety at 30 days

Nov 2, 2026, 12:40 PM ·Business Wire

FDA Approval of Edwards Lifesciences’ PASCAL Precision System Opens New Treatment Pathway for Patients With Tricuspid Valve Disease

Recent FDA Approval of PASCAL Ace with Capture Clarity Simplifies Mitral TEER Procedures for Clinicians Edwards Lifesciences Corporation (NYSE:EW) today announced that the U.S. Food and Drug Administration (FDA) has

Oct 21, 2026, 9:00 AM ·Business Wire

Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026

Edwards Lifesciences (NYSE:EW) plans to announce its operating results for the quarter ended Sept. 30, 2026 after the market closes on Wednesday, Nov. 4, and will host a conference call at 5:00 p.m. ET that day to

Oct 7, 2026, 6:00 AM ·Business Wire

Edwards Lifesciences to Host Investor Event in Conjunction With TCT

Edwards Lifesciences (NYSE:EW) today announced that it will host an investor event in conjunction with the TCT annual scientific symposium in San Diego on Monday, Nov. 2, from 5:00 to 6:00 PM Pacific Time. The meeting

Oct 5, 2026, 6:00 AM ·Business Wire

Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients

Edwards Lifesciences (NYSE:EW) today announced that the U.S. Food and Drug Administration (FDA) has approved the AUTUS Size-Adjustable Valve, a surgical pulmonary valve designed specifically for pediatric patients with

Oct 1, 2026, 4:26 PM ·Business Wire

Edwards Lifesciences Comments on TAVR National Coverage Decision

Edwards Lifesciences (NYSE:EW) today issued the following statement in response to the national coverage determination (NCD) for transcatheter aortic valve replacement (TAVR) released by the Centers for Medicare &

Sep 10, 2026, 5:49 PM ·Business Wire

Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket

Sep 7, 2026, 3:32 PM ·PRNewswire

Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit

Edwards Lifesciences Corporation (NYSE:EW) will participate in the Deutsche Bank Healthcare Summit on Wednesday, Sept. 16, 2026.Bernard Zovighian, chief executive officer, is scheduled to present at 10:00 a.m. ET.

Sep 2, 2026, 4:15 PM ·Business Wire

Edwards Lifesciences Reports Second Quarter Results

Edwards Lifesciences (NYSE:EW) today reported financial results for the quarter ended June 30, 2026. Highlights Q2 sales grew 13.6% to $1.74 billion1, constant currency2 sales grew 12.5% Q2 TAVR sales grew

Jul 23, 2026, 4:15 PM ·Business Wire

Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026

Edwards Lifesciences (NYSE:EW) plans to announce its operating results for the quarter ended June 30, 2026 after the market closes on Thursday July 23, and will host a conference call at 5:00 p.m. ET that day to discuss

Jul 16, 2026, 7:05 AM ·Business Wire

Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders?

Jul 3, 2026, 12:34 PM ·PRNewswire

Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves

Edwards Lifesciences (NYSE:EW) today announced new data presented at New York Valves 2026, the annual conference organized by the Cardiovascular Research Foundation, which reinforce the company's leadership in

Jun 26, 2026, 10:15 AM ·Business Wire

Edwards Lifesciences Corporation EW · News